The human microbiome refers to the microorganisms residing in various parts of the human body including the gastrointestinal tract, skin, vagina, lungs and others. These microorganisms play an important role in the overall health and wellness of humans. The human microbiome market comprises products such as prebiotics, probiotics, foods, dietary supplements, and others are that help maintain balance of microbes in the human body. These products regulate digestion, boost immunity, reduce inflammation and support overall health.

The global Human Microbiome Market is estimated to be valued at US$ 524.2 million in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising awareness about human microbiome and its role in health and disease prevention among consumers has been a key trend driving growth in this market. In recent years, extensive R&D investments by market players and research institutes regarding understanding the complex interplay between human microbiome and host has helped demonstrate human microbiome’s significance in regulating metabolic, immunological and neurological functions in humans. This has fostered interest among consumers to incorporate prebiotics and probiotics containing foods and supplements in their diet to achieve microbiome balance and improve their health. The commercial availability of microbiome testing kits has also encouraged self-monitoring of individual microbiome makeup and related health conditions, further propelling the demand for human microbiome-based products.

Segment Analysis
The global Human Microbiome Market is segmented into two broad categories based on product type: probiotics and prebiotics. The probiotics segment dominates the market currently due to growing awareness about gut health and importance of probiotics in maintaining a healthy microbiome. Probiotics help restore the balance of microorganisms and treat various digestive conditions.

Key Takeaways
The Global Human Microbiome Market Size is expected to witness high growth.

Regional analysis: North America region currently dominates the global Human Microbiome Market owing to rising health consciousness, growing geriatric population and favourable regulatory environment supporting innovations. However, Asia Pacific region is expected to witness fastest growth over the forecast period with China and India emerging as major markets. Investments in R&D and increasing acceptance of probiotic supplements will drive growth in the region.

Key players operating in the Human Microbiome Market are Enterome Bioscience, Rebiotix Inc., Seres Therapeutics, Vedanta Biosciences, Osel Inc. and Symberix. Companies are focusing on strengthening their probiotics portfolio and exploring microbiome-based therapies for various therapeutic areas including gastrointestinal disorders, metabolic disorders and women’s health. Partnerships with research institutes is another area companies are focusing on to boost research capabilities.

Get more insights on this topic:
https://www.dailyprbulletin.com/human-microbiome-market-analysis/

Check below trending articles on this topic:
https://www.rapidwebwire.com/telecom-towers-market-analysis-and-trends/